About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Vps35tm1.1Hckn
targeted mutation 1.1, Hendrik C Korswagen
MGI:5704327
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Vps35tm1.1Hckn/Vps35tm1.1Hckn
Tg(Vil1-cre/ERT2)23Syr/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 MGI:5749127


Genotype
MGI:5749127
cn1
Allelic
Composition
Vps35tm1.1Hckn/Vps35tm1.1Hckn
Tg(Vil1-cre/ERT2)23Syr/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Vil1-cre/ERT2)23Syr mutation (1 available)
Vps35tm1.1Hckn mutation (0 available); any Vps35 mutation (45 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

4-hydroxytamoxifen treated Vps35tm1.1Hckn/Vps35tm1.1Hckn Tg(Vil1-cre/ERT2)23Syr/0 mice exhibit no differences in small intestine crypt or villus morphology

digestive/alimentary system
N
• at 3 days, 1 week, 4 weeks and 8 weeks after 4-hydroxytamoxifen (4-OHT) injection, adult mice exhibit no differences in crypt or villus morphology in the small intestine relative to control littermates
• in culture, 4-OHT-treated small intestinal crypt organoids show reduced Wntless (Wls) protein levels but exhibit normal overall morphology, with Paneth cells visible at the tips of the bud, and can grow for many passages without Wnt supplementation in the growth medium
• 4-OHT-treated intestinal organoids show normal survival rates in different R-spondin concentrations
• 5 days after passaging, 4-OHT-treated intestinal organoids develop fewer crypt-like buds relative to control organoids, indicating a mild proliferation defect
• supplementation of exogenous Wnt3a in the medium does not fully rescue this growth defect, although 4-OHT-treated organoids can respond to Wnt signaling

cellular
• 5 days after passaging, 4-OHT-treated intestinal organoids develop fewer crypt-like buds relative to control organoids, indicating a mild proliferation defect
• supplementation of exogenous Wnt3a in the medium does not fully rescue this growth defect, although 4-OHT-treated organoids can respond to Wnt signaling





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory